U.S. markets closed

Summit Therapeutics Inc. (SMMT)

NasdaqGM - NasdaqGM Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
4.4400-0.0700 (-1.55%)
Al cierre: 04:00PM EDT
4.4200 -0.02 (-0.45%)
Fuera de horario: 05:18PM EDT

Transacciones de miembros de la gerencia

Divisa en USD
Compras de miembros de la gerencia en los últimos 6 mesesAccionesTrans
Compras00
VentasN/D0
Acciones netas compradas (vendidas)00
Acciones totales pertenecientes a miembros de la gerencia618.75MN/D
Acciones netas compradas (vendidas) en %N/DN/D
Compras institucionales netas del trimestre anterior al últimoAcciones
Acciones netas compradas (vendidas)N/D
Cambio en acciones institucionales propias en %N/D

Información confidencial de transacciones reportada (últimos dos años)

Miembro de la gerenciaTransacciónTipoValorFechaAcciones

ZANGANEH MAHKAM
Chief Executive Officer

Purchase at price 3.71 - 3.75 per share.Indirecto411,09427 mar 2024110,321

DHINGRA ANKUR
Chief Financial Officer

Purchase at price 3.75 per share.Indirecto375,00026 mar 2024100,000

DHINGRA ANKUR
Chief Financial Officer

Purchase at price 2.15 - 2.17 per share.Indirecto44,25413 dic 202320,400

ZANGANEH MAHKAM
Chief Executive Officer

Purchase at price 2.07 per share.Directo10,35012 dic 20235,000

ZANGANEH MAHKAM
Chief Executive Officer

Conversion of Exercise of derivative security at price 1.44 - 1.58 per share.Indirecto1,204,10811 dic 2023805,495

SONI MANMEET SINGH
Chief Operating Officer

Purchase at price 1.68 per share.Directo4,999,99913 oct 20232,976,190

ZANGANEH MAHKAM
Chief Executive Officer

Purchase at price 1.52 per share.Indirecto35,761,10708 mar 202323,527,044

ZANGANEH MAHKAM
Chief Executive Officer

Purchase at price 1.52 per share.Indirecto35,761,10708 mar 202323,527,044

DHINGRA ANKUR
Chief Financial Officer

Purchase at price 1.38 per share.Indirecto270,98007 mar 2023196,362

XIA YU
Director

Purchase at price 1.38 - 4.59 per share.Indirecto75,602,47107 mar 202331,523,530

DUGGAN ROBERT WILLIAM
Chief Executive Officer

Purchase at price 1.39 per share.Directo523,320,93306 mar 2023376,489,880

DUGGAN ROBERT WILLIAM
Chief Executive Officer

Purchase at price 0.97 per share.Directo92,003,72716 ago 202294,849,203

ZANGANEH MAHKAM
Chief Executive Officer

Purchase at price 0.97 per share.Indirecto5,634,85816 ago 20225,809,132

ZANGANEH MAKY
Chief Executive Officer

Purchase at price 0.97 per share.Indirecto5,634,85816 ago 20225,809,132

DHINGRA ANKUR
Chief Financial Officer

Purchase at price 0.97 per share.Indirecto35,12916 ago 202236,215

DHINGRA ANKUR
Chief Financial Officer

Purchase at price 0.97 per share.Indirecto36,55416 ago 202237,685

DUGGAN ROBERT WILLIAM
Chief Executive Officer

Purchase at price 5.24 per share.Directo59,557,42612 may 202111,365,921

ZANGANEH MAHKAM
Chief Operating Officer

Purchase at price 5.24 per share.Indirecto2,038,76312 may 2021389,077

ZANGANEH MAKY
Chief Operating Officer

Purchase at price 5.24 per share.Indirecto2,038,76312 may 2021389,077

POWELL DAVID JONATHAN
Officer

Sale at price 4.39 - 4.44 per share.Directo190,69430 nov 202043,282

POWELL DAVID JONATHAN
Officer

Conversion of Exercise of derivative security at price 1.79 - 1.92 per share.Directo79,63530 nov 202043,282

POWELL DAVID JONATHAN
Officer

Sale at price 4.21 - 4.40 per share.Directo130,77025 nov 202030,431

POWELL DAVID JONATHAN
Officer

Conversion of Exercise of derivative security at price 1.92 per share.Directo58,42825 nov 202030,431

DUGGAN ROBERT WILLIAM
Chief Executive Officer

Purchase at price 3.34 per share.Directo46,999,99906 nov 202014,071,856